Atlas Trials

Recurrent Gastrointestinal Carcinoid Tumor

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Gastrointestinal Carcinoid Tumor

RecordFirmDate
Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors (NCT02259725)University of Southern California2016-08-16
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT01155258)University of Southern California2010-06-01
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer (NCT00397384)National Cancer Institute (NCI)2007-01-01
Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors (NCT00131911)National Cancer Institute (NCI)2005-06-01
Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors (NCT00655655)Mayo Clinic2004-12-01
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer (NCT00087191)National Cancer Institute (NCI)2004-05-01
Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors (NCT00084461)National Cancer Institute (NCI)2004-03-01
Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma (NCT00093782)National Cancer Institute (NCI)2003-12-01
Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors (NCT00075439)National Cancer Institute (NCI)2003-12-01
Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors (NCT00055809)National Cancer Institute (NCI)2003-01-01
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) (NCT00031681)National Cancer Institute (NCI)2001-12-01
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074)National Cancer Institute (NCI)1999-08-01

Track Recurrent Gastrointestinal Carcinoid Tumor automatically

Every clearance here is in the API, with alerts when new ones post.